Last 12 months
Inside the activity.
1 purchase rows · 28 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 15 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 7 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 11, 2020 Filed Feb 13, 2020 21:10 UTC |
Doudna Jennifer ADirector
|
GrantDeferred Share Units · Derivative | 1,221 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-002165 · doc4.xml · derivative · entry 1 Doudna Jennifer A · CIK 0001739090 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,662.092 Underlying: Common Stock · 1,221 shares Expires not disclosed F1 · derivative.exercise_price: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.expiration_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). Read SEC document |
| February 11, 2020 Filed Feb 13, 2020 21:10 UTC |
PEREZ WILLIAM DDirector
|
GrantDeferred Share Units · Derivative | 1,221 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-002167 · doc4.xml · derivative · entry 2 PEREZ WILLIAM D · CIK 0001184649 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,151.71 Underlying: Common Stock · 1,221 shares Expires not disclosed F1 · derivative.exercise_price: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.expiration_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). Read SEC document |
| February 10, 2020 Filed Feb 12, 2020 23:47 UTC |
Taubert Jennifer LEVP, WW Chair, Pharmaceuticals
|
GrantRestricted Share Units · Derivative | 3,570 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-002101 · doc4.xml · derivative · entry 3 Taubert Jennifer L · CIK 0001745938 · EVP, WW Chair, Pharmaceuticals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,570 Underlying: Common Stock · 3,570 shares Expires not disclosed F3 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. F3 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. Read SEC document |
| February 10, 2020 Filed Feb 12, 2020 23:47 UTC |
Taubert Jennifer LEVP, WW Chair, Pharmaceuticals
|
GrantPerformance Share Units · Derivative | 8,360 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-002101 · doc4.xml · derivative · entry 2 Taubert Jennifer L · CIK 0001745938 · EVP, WW Chair, Pharmaceuticals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,360 Underlying: Common Stock · 8,360 shares Expires not disclosed F2 · derivative.exercise_price: On February 10, 2020, the Issuer's Compensation & Benefits Committee certified the performance factor applicable to Performance Share Units awarded to the reporting person on February 13, 2017 under the Issuer's Long-Term Incentive Plan. These Performance Share Units represent a contingent right to an equal number of shares of Common Stock or the cash value thereof, subject to the reporting person's continued service to the Issuer through the third anniversary of the initial award date F2 · derivative.expiration_date: On February 10, 2020, the Issuer's Compensation & Benefits Committee certified the performance factor applicable to Performance Share Units awarded to the reporting person on February 13, 2017 under the Issuer's Long-Term Incentive Plan. These Performance Share Units represent a contingent right to an equal number of shares of Common Stock or the cash value thereof, subject to the reporting person's continued service to the Issuer through the third anniversary of the initial award date Read SEC document |
| February 10, 2020 Filed Feb 12, 2020 23:47 UTC |
Taubert Jennifer LEVP, WW Chair, Pharmaceuticals
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 91,324 | $0.00 Strike: $151.41 | $0.00 |
DisclosureSEC source: 0001225208-20-002101 · doc4.xml · derivative · entry 1 Taubert Jennifer L · CIK 0001745938 · EVP, WW Chair, Pharmaceuticals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,324 Underlying: Common Stock · 91,324 shares Expires 2030-02-10 F1 · security: Awarded under Issuer's Long-Term Incentive Plan. Read SEC document |
| February 10, 2020 Filed Feb 12, 2020 23:47 UTC |
Ullmann Michael HExec VP, General Counsel
|
GrantRestricted Share Units · Derivative | 2,499 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-002102 · doc4.xml · derivative · entry 7 Ullmann Michael H · CIK 0001537710 · Exec VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,499 Underlying: Common Stock · 2,499 shares Expires not disclosed F6 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. F6 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. Read SEC document |
| February 10, 2020 Filed Feb 12, 2020 23:47 UTC |
Ullmann Michael HExec VP, General Counsel
|
GrantPerformance Share Units · Derivative | 14,290 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-002102 · doc4.xml · derivative · entry 6 Ullmann Michael H · CIK 0001537710 · Exec VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,290 Underlying: Common Stock · 14,290 shares Expires not disclosed F5 · derivative.exercise_price: On February 10, 2020, the Issuer's Compensation & Benefits Committee certified the performance factor applicable to Performance Share Units awarded to the reporting person on February 13, 2017 under the Issuer's Long-Term Incentive Plan. These Performance Share Units represent a contingent right to an equal number of shares of Common Stock or the cash value thereof, subject to the reporting person's continued service to the Issuer through the third anniversary of the initial award date F5 · derivative.expiration_date: On February 10, 2020, the Issuer's Compensation & Benefits Committee certified the performance factor applicable to Performance Share Units awarded to the reporting person on February 13, 2017 under the Issuer's Long-Term Incentive Plan. These Performance Share Units represent a contingent right to an equal number of shares of Common Stock or the cash value thereof, subject to the reporting person's continued service to the Issuer through the third anniversary of the initial award date Read SEC document |
| February 10, 2020 Filed Feb 12, 2020 23:47 UTC |
Ullmann Michael HExec VP, General Counsel
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 63,927 | $0.00 Strike: $151.41 | $0.00 |
DisclosureSEC source: 0001225208-20-002102 · doc4.xml · derivative · entry 5 Ullmann Michael H · CIK 0001537710 · Exec VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,927 Underlying: Common Stock · 63,927 shares Expires 2030-02-10 F4 · security: Awarded under Issuer's Long-Term Incentive Plan. Read SEC document |
| February 10, 2020 Filed Feb 12, 2020 23:47 UTC |
Wengel Kathryn EEVP, Chief GSC Officer
|
GrantRestricted Share Units · Derivative | 1,807 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-002103 · doc4.xml · derivative · entry 3 Wengel Kathryn E · CIK 0001745955 · EVP, Chief GSC Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,807 Underlying: Common Stock · 1,807 shares Expires not disclosed F4 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. F4 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. Read SEC document |
| February 10, 2020 Filed Feb 12, 2020 23:47 UTC |
Wengel Kathryn EEVP, Chief GSC Officer
|
GrantPerformance Share Units · Derivative | 8,217 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-002103 · doc4.xml · derivative · entry 2 Wengel Kathryn E · CIK 0001745955 · EVP, Chief GSC Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,217 Underlying: Common Stock · 8,217 shares Expires not disclosed F2 · derivative.exercise_price: On February 10, 2020, the Issuer's Compensation & Benefits Committee certified the performance factor applicable to Performance Share Units awarded to the reporting person on February 13, 2017 under the Issuer's Long-Term Incentive Plan. These Performance Share Units represent a contingent right to an equal number of shares of Common Stock or the cash value thereof, subject to the reporting person's continued service to the Issuer through the third anniversary of the initial award date F3 · derivative.expiration_date: On February 10, 2020, the Issuer's Compensation & Benefits Committee certified the performance factor applicable to Performance Share Units awarded to the reporting person on February 13, 2017 under the Issuer's Long-Term Incentive Plan. These Performance Share Units represent a contingent right to an equal number of shares of Common Stock or the cash value thereof, subject to the reporting person's continued service to the Issuer through the third anniversary of the initial award date Read SEC document |
| February 10, 2020 Filed Feb 12, 2020 23:47 UTC |
Wengel Kathryn EEVP, Chief GSC Officer
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 46,210 | $0.00 Strike: $151.41 | $0.00 |
DisclosureSEC source: 0001225208-20-002103 · doc4.xml · derivative · entry 1 Wengel Kathryn E · CIK 0001745955 · EVP, Chief GSC Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,210 Underlying: Common Stock · 46,210 shares Expires 2030-02-10 F1 · security: Awarded under Issuer's Long-Term Incentive Plan. Read SEC document |
| February 10, 2020 Filed Feb 12, 2020 23:47 UTC |
Wolk Joseph JExec VP, CFO
|
GrantRestricted Share Units · Derivative | 3,449 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-002104 · doc4.xml · derivative · entry 3 Wolk Joseph J · CIK 0001744564 · Exec VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,449 Underlying: Common Stock · 3,449 shares Expires not disclosed F3 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. F3 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. Read SEC document |
| February 10, 2020 Filed Feb 12, 2020 23:47 UTC |
Wolk Joseph JExec VP, CFO
|
GrantPerformance Share Units · Derivative | 3,680 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-002104 · doc4.xml · derivative · entry 2 Wolk Joseph J · CIK 0001744564 · Exec VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,680 Underlying: Common Stock · 3,680 shares Expires not disclosed F2 · derivative.exercise_price: On February 10, 2020, the Issuer's Compensation & Benefits Committee certified the performance factor applicable to Performance Share Units awarded to the reporting person on February 13, 2017 under the Issuer's Long-Term Incentive Plan. These Performance Share Units represent a contingent right to an equal number of shares of Common Stock or the cash value thereof, subject to the reporting person's continued service to the Issuer through the third anniversary of the initial award date F2 · derivative.expiration_date: On February 10, 2020, the Issuer's Compensation & Benefits Committee certified the performance factor applicable to Performance Share Units awarded to the reporting person on February 13, 2017 under the Issuer's Long-Term Incentive Plan. These Performance Share Units represent a contingent right to an equal number of shares of Common Stock or the cash value thereof, subject to the reporting person's continued service to the Issuer through the third anniversary of the initial award date Read SEC document |
| February 10, 2020 Filed Feb 12, 2020 23:47 UTC |
Wolk Joseph JExec VP, CFO
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 88,219 | $0.00 Strike: $151.41 | $0.00 |
DisclosureSEC source: 0001225208-20-002104 · doc4.xml · derivative · entry 1 Wolk Joseph J · CIK 0001744564 · Exec VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,219 Underlying: Common Stock · 88,219 shares Expires 2030-02-10 F1 · security: Awarded under Issuer's Long-Term Incentive Plan. Read SEC document |
| February 10, 2020 Filed Feb 12, 2020 23:47 UTC |
Decker Robert JController, CAO
|
GrantRestricted Share Units · Derivative | 581 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-002105 · doc4.xml · derivative · entry 3 Decker Robert J · CIK 0001798703 · Controller, CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 581 Underlying: Common Stock · 581 shares Expires not disclosed F4 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. F4 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. Read SEC document |
| February 10, 2020 Filed Feb 12, 2020 23:47 UTC |
Decker Robert JController, CAO
|
GrantPerformance Share Units · Derivative | 779 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-002105 · doc4.xml · derivative · entry 2 Decker Robert J · CIK 0001798703 · Controller, CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 779 Underlying: Common Stock · 779 shares Expires not disclosed F2 · derivative.exercise_price: On February 10, 2020, the Issuer's Compensation & Benefits Committee certified the performance factor applicable to Performance Share Units awarded to the reporting person on February 13, 2017 under the Issuer's Long-Term Incentive Plan. These Performance Share Units represent a contingent right to an equal number of shares of Common Stock or the cash value thereof, subject to the reporting person's continued service to the Issuer through the third anniversary of the initial award date F3 · derivative.expiration_date: On February 10, 2020, the Issuer's Compensation & Benefits Committee certified the performance factor applicable to Performance Share Units awarded to the reporting person on February 13, 2017 under the Issuer's Long-Term Incentive Plan. These Performance Share Units represent a contingent right to an equal number of shares of Common Stock or the cash value thereof, subject to the reporting person's continued service to the Issuer through the third anniversary of the initial award date Read SEC document |
| February 10, 2020 Filed Feb 12, 2020 23:47 UTC |
Decker Robert JController, CAO
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 7,425 | $0.00 Strike: $151.41 | $0.00 |
DisclosureSEC source: 0001225208-20-002105 · doc4.xml · derivative · entry 1 Decker Robert J · CIK 0001798703 · Controller, CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,425 Underlying: Common Stock · 7,425 shares Expires 2030-02-10 F1 · security: Awarded under Issuer's Long-Term Incentive Plan. Read SEC document |
| February 10, 2020 Filed Feb 13, 2020 00:31 UTC |
Fasolo PeterExec VP, Chief HR Officer
|
GrantRestricted Share Units · Derivative | 2,078 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-002107 · doc4.xml · derivative · entry 3 Fasolo Peter · CIK 0001509999 · Exec VP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,078 Underlying: Common Stock · 2,078 shares Expires not disclosed F3 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. F3 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. Read SEC document |
| February 10, 2020 Filed Feb 13, 2020 00:31 UTC |
Fasolo PeterExec VP, Chief HR Officer
|
GrantPerformance Share Units · Derivative | 15,629 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-002107 · doc4.xml · derivative · entry 2 Fasolo Peter · CIK 0001509999 · Exec VP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,629 Underlying: Common Stock · 15,629 shares Expires not disclosed F2 · derivative.exercise_price: On February 10, 2020, the Issuer's Compensation & Benefits Committee certified the performance factor applicable to Performance Share Units awarded to the reporting person on February 13, 2017 under the Issuer's Long-Term Incentive Plan. These Performance Share Units represent a contingent right to an equal number of shares of Common Stock or the cash value thereof, subject to the reporting person's continued service to the Issuer through the third anniversary of the initial award date F2 · derivative.expiration_date: On February 10, 2020, the Issuer's Compensation & Benefits Committee certified the performance factor applicable to Performance Share Units awarded to the reporting person on February 13, 2017 under the Issuer's Long-Term Incentive Plan. These Performance Share Units represent a contingent right to an equal number of shares of Common Stock or the cash value thereof, subject to the reporting person's continued service to the Issuer through the third anniversary of the initial award date Read SEC document |
| February 10, 2020 Filed Feb 13, 2020 00:31 UTC |
Fasolo PeterExec VP, Chief HR Officer
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 53,151 | $0.00 Strike: $151.41 | $0.00 |
DisclosureSEC source: 0001225208-20-002107 · doc4.xml · derivative · entry 1 Fasolo Peter · CIK 0001509999 · Exec VP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,151 Underlying: Common Stock · 53,151 shares Expires 2030-02-10 F1 · security: Awarded under Issuer's Long-Term Incentive Plan. Read SEC document |
| February 10, 2020 Filed Feb 13, 2020 00:31 UTC |
Duato JoaquinVice Chair, Exec Committee
|
GrantRestricted Share Units · Derivative | 5,220 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-002106 · doc4.xml · derivative · entry 3 Duato Joaquin · CIK 0001673401 · Vice Chair, Exec Committee 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,220 Underlying: Common Stock · 5,220 shares Expires not disclosed F3 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. F3 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. Read SEC document |
| February 10, 2020 Filed Feb 13, 2020 00:31 UTC |
Duato JoaquinVice Chair, Exec Committee
|
GrantPerformance Share Units · Derivative | 24,561 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-002106 · doc4.xml · derivative · entry 2 Duato Joaquin · CIK 0001673401 · Vice Chair, Exec Committee 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,561 Underlying: Common Stock · 24,561 shares Expires not disclosed F2 · derivative.exercise_price: On February 10, 2020, the Issuer's Compensation & Benefits Committee certified the performance factor applicable to Performance Share Units awarded to the reporting person on February 13, 2017 under the Issuer's Long-Term Incentive Plan. These Performance Share Units represent a contingent right to an equal number of shares of Common Stock or the cash value thereof, subject to the reporting person's continued service to the Issuer through the third anniversary of the initial award date F2 · derivative.expiration_date: On February 10, 2020, the Issuer's Compensation & Benefits Committee certified the performance factor applicable to Performance Share Units awarded to the reporting person on February 13, 2017 under the Issuer's Long-Term Incentive Plan. These Performance Share Units represent a contingent right to an equal number of shares of Common Stock or the cash value thereof, subject to the reporting person's continued service to the Issuer through the third anniversary of the initial award date Read SEC document |
| February 10, 2020 Filed Feb 13, 2020 00:31 UTC |
Duato JoaquinVice Chair, Exec Committee
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 133,516 | $0.00 Strike: $151.41 | $0.00 |
DisclosureSEC source: 0001225208-20-002106 · doc4.xml · derivative · entry 1 Duato Joaquin · CIK 0001673401 · Vice Chair, Exec Committee 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,516 Underlying: Common Stock · 133,516 shares Expires 2030-02-10 F1 · security: Awarded under Issuer's Long-Term Incentive Plan. Read SEC document |
| February 10, 2020 Filed Feb 13, 2020 00:31 UTC |
Gorsky AlexDirector · Chairman, CEO
|
GrantRestricted Share Units · Derivative | 10,432 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-002108 · doc4.xml · derivative · entry 3 Gorsky Alex · CIK 0001453149 · Director · Chairman, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,432 Underlying: Common Stock · 10,432 shares Expires not disclosed F3 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. F3 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. Read SEC document |
| February 10, 2020 Filed Feb 13, 2020 00:31 UTC |
Gorsky AlexDirector · Chairman, CEO
|
GrantPerformance Share Units · Derivative | 75,237 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-002108 · doc4.xml · derivative · entry 2 Gorsky Alex · CIK 0001453149 · Director · Chairman, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,237 Underlying: Common Stock · 75,237 shares Expires not disclosed F2 · derivative.exercise_price: Effective February 10, 2020, the Issuer's Board certified the performance factor applicable to Performance Share Units awarded to the reporting person on February 13, 2017 under the Issuer's Long-Term Incentive Plan. These Performance Share Units represent a contingent right to an equal number of shares of Common Stock or the cash value thereof, subject to the reporting person's continued service to the Issuer through the third anniversary of the initial award date F2 · derivative.expiration_date: Effective February 10, 2020, the Issuer's Board certified the performance factor applicable to Performance Share Units awarded to the reporting person on February 13, 2017 under the Issuer's Long-Term Incentive Plan. These Performance Share Units represent a contingent right to an equal number of shares of Common Stock or the cash value thereof, subject to the reporting person's continued service to the Issuer through the third anniversary of the initial award date Read SEC document |
| February 10, 2020 Filed Feb 13, 2020 00:31 UTC |
Gorsky AlexDirector · Chairman, CEO
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 266,849 | $0.00 Strike: $151.41 | $0.00 |
DisclosureSEC source: 0001225208-20-002108 · doc4.xml · derivative · entry 1 Gorsky Alex · CIK 0001453149 · Director · Chairman, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 266,849 Underlying: Common Stock · 266,849 shares Expires 2030-02-10 F1 · security: Awarded under Issuer's Long-Term Incentive Plan. Read SEC document |
| February 10, 2020 Filed Feb 13, 2020 00:31 UTC |
McEvoy AshleyEVP, WW Chair, Medical Devices
|
GrantRestricted Share Units · Derivative | 2,999 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-002109 · doc4.xml · derivative · entry 3 McEvoy Ashley · CIK 0001745936 · EVP, WW Chair, Medical Devices 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,999 Underlying: Common Stock · 2,999 shares Expires not disclosed F4 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. F4 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. Read SEC document |
| February 10, 2020 Filed Feb 13, 2020 00:31 UTC |
McEvoy AshleyEVP, WW Chair, Medical Devices
|
GrantPerformance Share Units · Derivative | 7,145 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-002109 · doc4.xml · derivative · entry 2 McEvoy Ashley · CIK 0001745936 · EVP, WW Chair, Medical Devices 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,145 Underlying: Common Stock · 7,145 shares Expires not disclosed F2 · derivative.exercise_price: On February 10, 2020, the Issuer's Compensation & Benefits Committee certified the performance factor applicable to Performance Share Units awarded to the reporting person on February 13, 2017 under the Issuer's Long-Term Incentive Plan. These Performance Share Units represent a contingent right to an equal number of shares of Common Stock or the cash value thereof, subject to the reporting person's continued service to the Issuer through the third anniversary of the initial award date F3 · derivative.expiration_date: On February 10, 2020, the Issuer's Compensation & Benefits Committee certified the performance factor applicable to Performance Share Units awarded to the reporting person on February 13, 2017 under the Issuer's Long-Term Incentive Plan. These Performance Share Units represent a contingent right to an equal number of shares of Common Stock or the cash value thereof, subject to the reporting person's continued service to the Issuer through the third anniversary of the initial award date Read SEC document |
| February 10, 2020 Filed Feb 13, 2020 00:31 UTC |
McEvoy AshleyEVP, WW Chair, Medical Devices
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 76,712 | $0.00 Strike: $151.41 | $0.00 |
DisclosureSEC source: 0001225208-20-002109 · doc4.xml · derivative · entry 1 McEvoy Ashley · CIK 0001745936 · EVP, WW Chair, Medical Devices 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,712 Underlying: Common Stock · 76,712 shares Expires 2030-02-10 F1 · security: Awarded under Issuer's Long-Term Incentive Plan. Read SEC document |
| February 10, 2020 Filed Feb 13, 2020 00:32 UTC |
Mongon ThibautExec VP, WW Chair, Consumer
|
GrantRestricted Share Units · Derivative | 2,285 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-002110 · doc4.xml · derivative · entry 3 Mongon Thibaut · CIK 0001768503 · Exec VP, WW Chair, Consumer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,285 Underlying: Common Stock · 2,285 shares Expires not disclosed F4 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. F4 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. Read SEC document |
| February 10, 2020 Filed Feb 13, 2020 00:32 UTC |
Mongon ThibautExec VP, WW Chair, Consumer
|
GrantPerformance Share Units · Derivative | 1,919 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-002110 · doc4.xml · derivative · entry 2 Mongon Thibaut · CIK 0001768503 · Exec VP, WW Chair, Consumer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,919 Underlying: Common Stock · 1,919 shares Expires not disclosed F2 · derivative.exercise_price: On February 10, 2020, the Issuer's Compensation & Benefits Committee certified the performance factor applicable to Performance Share Units awarded to the reporting person on February 13, 2017 under the Issuer's Long-Term Incentive Plan. These Performance Share Units represent a contingent right to an equal number of shares of Common Stock or the cash value thereof, subject to the reporting person's continued service to the Issuer through the third anniversary of the initial award date F3 · derivative.expiration_date: On February 10, 2020, the Issuer's Compensation & Benefits Committee certified the performance factor applicable to Performance Share Units awarded to the reporting person on February 13, 2017 under the Issuer's Long-Term Incentive Plan. These Performance Share Units represent a contingent right to an equal number of shares of Common Stock or the cash value thereof, subject to the reporting person's continued service to the Issuer through the third anniversary of the initial award date Read SEC document |
| February 10, 2020 Filed Feb 13, 2020 00:32 UTC |
Mongon ThibautExec VP, WW Chair, Consumer
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 58,447 | $0.00 Strike: $151.41 | $0.00 |
DisclosureSEC source: 0001225208-20-002110 · doc4.xml · derivative · entry 1 Mongon Thibaut · CIK 0001768503 · Exec VP, WW Chair, Consumer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,447 Underlying: Common Stock · 58,447 shares Expires 2030-02-10 F1 · security: Awarded under Issuer's Long-Term Incentive Plan. Read SEC document |
| February 10, 2020 Filed Feb 13, 2020 00:32 UTC |
Sneed Michael EEVP, Global Corp Aff & COO
|
GrantRestricted Share Units · Derivative | 1,378 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-002111 · doc4.xml · derivative · entry 3 Sneed Michael E · CIK 0001745939 · EVP, Global Corp Aff & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,378 Underlying: Common Stock · 1,378 shares Expires not disclosed F4 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. F4 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. Read SEC document |
| February 10, 2020 Filed Feb 13, 2020 00:32 UTC |
Sneed Michael EEVP, Global Corp Aff & COO
|
GrantPerformance Share Units · Derivative | 6,152 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-002111 · doc4.xml · derivative · entry 2 Sneed Michael E · CIK 0001745939 · EVP, Global Corp Aff & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,152 Underlying: Common Stock · 6,152 shares Expires not disclosed F2 · derivative.exercise_price: On February 10, 2020, the Issuer's Compensation & Benefits Committee certified the performance factor applicable to Performance Share Units awarded to the reporting person on February 13, 2017 under the Issuer's Long-Term Incentive Plan. These Performance Share Units represent a contingent right to an equal number of shares of Common Stock or the cash value thereof, subject to the reporting person's continued service to the Issuer through the third anniversary of the initial award date F3 · derivative.expiration_date: On February 10, 2020, the Issuer's Compensation & Benefits Committee certified the performance factor applicable to Performance Share Units awarded to the reporting person on February 13, 2017 under the Issuer's Long-Term Incentive Plan. These Performance Share Units represent a contingent right to an equal number of shares of Common Stock or the cash value thereof, subject to the reporting person's continued service to the Issuer through the third anniversary of the initial award date Read SEC document |
| February 10, 2020 Filed Feb 13, 2020 00:32 UTC |
Sneed Michael EEVP, Global Corp Aff & COO
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 35,251 | $0.00 Strike: $151.41 | $0.00 |
DisclosureSEC source: 0001225208-20-002111 · doc4.xml · derivative · entry 1 Sneed Michael E · CIK 0001745939 · EVP, Global Corp Aff & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,251 Underlying: Common Stock · 35,251 shares Expires 2030-02-10 F1 · security: Awarded under Issuer's Long-Term Incentive Plan. Read SEC document |
| February 10, 2020 Filed Feb 13, 2020 00:32 UTC |
Stoffels PaulusVice Chair, Exec Committee
|
GrantRestricted Share Units · Derivative | 5,241 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-002112 · doc4.xml · derivative · entry 3 Stoffels Paulus · CIK 0001559387 · Vice Chair, Exec Committee 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,241 Underlying: Common Stock · 5,241 shares Expires not disclosed F4 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. F4 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. Read SEC document |
| February 10, 2020 Filed Feb 13, 2020 00:32 UTC |
Stoffels PaulusVice Chair, Exec Committee
|
GrantPerformance Share Units · Derivative | 27,686 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-002112 · doc4.xml · derivative · entry 2 Stoffels Paulus · CIK 0001559387 · Vice Chair, Exec Committee 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,686 Underlying: Common Stock · 27,686 shares Expires not disclosed F2 · derivative.exercise_price: On February 10, 2020, the Issuer's Compensation & Benefits Committee certified the performance factor applicable to Performance Share Units awarded to the reporting person on February 13, 2017 under the Issuer's Long-Term Incentive Plan. These Performance Share Units represent a contingent right to an equal number of shares of Common Stock or the cash value thereof, subject to the reporting person's continued service to the Issuer through the third anniversary of the initial award date F3 · derivative.expiration_date: On February 10, 2020, the Issuer's Compensation & Benefits Committee certified the performance factor applicable to Performance Share Units awarded to the reporting person on February 13, 2017 under the Issuer's Long-Term Incentive Plan. These Performance Share Units represent a contingent right to an equal number of shares of Common Stock or the cash value thereof, subject to the reporting person's continued service to the Issuer through the third anniversary of the initial award date Read SEC document |
| February 10, 2020 Filed Feb 13, 2020 00:32 UTC |
Stoffels PaulusVice Chair, Exec Committee
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 134,064 | $0.00 Strike: $151.41 | $0.00 |
DisclosureSEC source: 0001225208-20-002112 · doc4.xml · derivative · entry 1 Stoffels Paulus · CIK 0001559387 · Vice Chair, Exec Committee 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,064 Underlying: Common Stock · 134,064 shares Expires 2030-02-10 F1 · security: Awarded under Issuer's Long-Term Incentive Plan. Read SEC document |
| February 03, 2020 Filed Feb 5, 2020 00:31 UTC |
Taubert Jennifer LEVP, WW Chair, Pharmaceuticals
|
Exercise / conversionRestricted Share Units · Derivative | 48,312 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-001596 · doc4.xml · derivative · entry 3 Taubert Jennifer L · CIK 0001745938 · EVP, WW Chair, Pharmaceuticals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 48,312 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 1, 2017; converted into shares of Common Stock upon vesting. F1 · derivative.expiration_date: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 1, 2017; converted into shares of Common Stock upon vesting. Read SEC document |
| February 03, 2020 Filed Feb 5, 2020 00:31 UTC |
Taubert Jennifer LEVP, WW Chair, Pharmaceuticals
|
Tax withholdingCommon Stock | 23,721 | $149.32 | $3,542,019.72 |
DisclosureSEC source: 0001225208-20-001596 · doc4.xml · nonDerivative · entry 2 Taubert Jennifer L · CIK 0001745938 · EVP, WW Chair, Pharmaceuticals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,729.001 F2 · shares: Shares withheld for payment of taxes upon vesting of Restricted Share Units. Read SEC document |
| February 03, 2020 Filed Feb 5, 2020 00:31 UTC |
Taubert Jennifer LEVP, WW Chair, Pharmaceuticals
|
Exercise / conversionCommon Stock | 48,312 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-001596 · doc4.xml · nonDerivative · entry 1 Taubert Jennifer L · CIK 0001745938 · EVP, WW Chair, Pharmaceuticals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,450.001 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 1, 2017; converted into shares of Common Stock upon vesting. Read SEC document |
| February 03, 2020 Filed Feb 5, 2020 00:31 UTC |
McEvoy AshleyEVP, WW Chair, Medical Devices
|
Exercise / conversionRestricted Share Units · Derivative | 38,650 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-001597 · doc4.xml · derivative · entry 5 McEvoy Ashley · CIK 0001745936 · EVP, WW Chair, Medical Devices 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 38,650 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 1, 2017; converted into shares of Common Stock upon vesting. F1 · derivative.expiration_date: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 1, 2017; converted into shares of Common Stock upon vesting. Read SEC document |
| February 03, 2020 Filed Feb 5, 2020 00:31 UTC |
McEvoy AshleyEVP, WW Chair, Medical Devices
|
Tax withholdingCommon Stock | 15,405 | $149.32 | $2,300,274.60 |
DisclosureSEC source: 0001225208-20-001597 · doc4.xml · nonDerivative · entry 2 McEvoy Ashley · CIK 0001745936 · EVP, WW Chair, Medical Devices 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,748.5197 Read SEC document |
| February 03, 2020 Filed Feb 5, 2020 00:31 UTC |
McEvoy AshleyEVP, WW Chair, Medical Devices
|
Exercise / conversionCommon Stock | 38,650 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-001597 · doc4.xml · nonDerivative · entry 1 McEvoy Ashley · CIK 0001745936 · EVP, WW Chair, Medical Devices 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,153.5197 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 1, 2017; converted into shares of Common Stock upon vesting. Read SEC document |
| January 30, 2020 Filed Feb 3, 2020 23:28 UTC |
Sneed Michael EEVP, Global Corp Aff & COO
|
Exercise / conversionEmployee Stock Options (Right to Buy) · Derivative | 58,128 | $0.00 Strike: $62.62 | $0.00 |
DisclosureSEC source: 0001225208-20-001519 · doc4.xml · derivative · entry 5 Sneed Michael E · CIK 0001745939 · EVP, Global Corp Aff & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 58,128 shares Expires 2020-02-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 30, 2020 Filed Feb 3, 2020 23:28 UTC |
Sneed Michael EEVP, Global Corp Aff & COO
|
SaleCommon Stock | 58,128 | $149.39 | $8,683,567.54 |
DisclosureSEC source: 0001225208-20-001519 · doc4.xml · nonDerivative · entry 2 Sneed Michael E · CIK 0001745939 · EVP, Global Corp Aff & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,383 F1 · price: This transaction was executed in multiple trades at prices ranging from $149.33 to $149.50. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| January 30, 2020 Filed Feb 3, 2020 23:28 UTC |
Sneed Michael EEVP, Global Corp Aff & COO
|
Exercise / conversionCommon Stock | 58,128 | $62.62 | $3,639,975.36 |
DisclosureSEC source: 0001225208-20-001519 · doc4.xml · nonDerivative · entry 1 Sneed Michael E · CIK 0001745939 · EVP, Global Corp Aff & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,511 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 13, 2019 Filed Dec 16, 2019 21:40 UTC |
Joly HubertDirector
|
PurchaseCommon Stock | 5,000 | $141.28 | $706,399.00 |
DisclosureSEC source: 0001225208-19-015852 · doc4.xml · nonDerivative · entry 1 Joly Hubert · CIK 0001467638 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Read SEC document |
| December 12, 2019 Filed Dec 16, 2019 22:40 UTC |
Wengel Kathryn EEVP, Chief GSC Officer
|
Exercise / conversionEmployee Stock Options (Right to Buy) · Derivative | 2,017 | $0.00 Strike: $62.62 | $0.00 |
DisclosureSEC source: 0001225208-19-015859 · doc4.xml · derivative · entry 5 Wengel Kathryn E · CIK 0001745955 · EVP, Chief GSC Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,017 shares Expires 2020-02-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Awarded under Issuer's Stock Option Plan and exercisable in full after the third anniversary of the grant. Read SEC document |
| December 12, 2019 Filed Dec 16, 2019 22:40 UTC |
Wengel Kathryn EEVP, Chief GSC Officer
|
SaleCommon Stock | 2,017 | $141.07 | $284,538.19 |
DisclosureSEC source: 0001225208-19-015859 · doc4.xml · nonDerivative · entry 2 Wengel Kathryn E · CIK 0001745955 · EVP, Chief GSC Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,719.2521 F1 · price: This transaction was executed in multiple trades at prices ranging from 141.04 to $141.07. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.